1. Introduction {#s0005}
===============

Inflammatory mediators are key signaling molecules implicated in the activation and regulation of inflammatory processes and are produced by various hematopoietic and non-hematopoietic cell types ([@b0130], [@b0255]). One of the most important mediators of the immune response is the nitric oxide (NO) radical produced by the inducible nitric oxide synthase (iNOS). This small molecule is not only essential for host innate immune response but also has a pivotal physiological role in the regulation of vasodilatation, neuronal transmission, cardiac contraction, stem cell differentiation and proliferation ([@b0160]). However, when iNOS activity is aberrant it has detrimental consequences and promotes multiple human diseases ([@b0195]). Thus, NO is a fundamental molecule for inflammation development and resolution. Given the simplicity of the NO measure trough the Griess reaction, the employment of activated immune cells (i.e. macrophages) has been established as a fast, economic and high-throughput alternative, not only to measure the anti-inflammatory potential of a molecule, but as a great criteria for bioassay-guided fractionation ([@b0305]).

Chronic anti-inflammatory therapy carries several unwanted secondary effects and poses burden on the patients, reducing therapeutic adherence and compromising the effectiveness of the treatment ([@b0280]). To address this, drug discovery research has focused on synthetic and computational methods, leaving aside bioprospecting as an alternative to identify new chemical entities ([@b0170], [@b0220]). Despite this, medicinal plants have been a major source of bioactive molecules for years and continue to be an essential alternative when it comes to health care in many places around the world, especially the rural areas of developing countries, where socio-economic factors difficult the access to modern drugs and health care systems ([@b0060]). In countries like Colombia, with more than 10% of the global biodiversity, folk medicine is used as a primary health care, by communities with knowledge and regular access to medicinal plants ([@b0115]). In this context, ethnopharmacological research and bio-guided isolation of active secondary metabolites remain a crucial strategy in the discovery of safer and more effective drugs ([@b0180]).

The Colombian Caribbean region has unique geographical and topographical features that had molded not only an extremely diverse flora and fauna, but also a great cultural diversity based on a wide ethnopharmacological knowledge centered on natural resources ([@b0115]). Despite Colombian government efforts to protect natural biodiversity and traditions related to medicinal plants, factors like discrimination to minorities, forced migrations and lack of policies, have affected the preservation of unique traditions to Colombian culture ([@b0115], [@b0215], [@b0290]).

In an effort to document and increase the attention to biodiversity conservation and ethnopharmacology, our research group started a bioprospecting program based on traditional knowledge of anti-inflammatory plants from the Colombia Caribbean region. The aim of this work was to assess the effect of 10 plants frequently used in the folk medicine to treat inflammation related diseases and that have been previously reported for its traditional uses ([Table 1](#t0005){ref-type="table"}.). Anti-inflammatory potential was assessed using the NO production in lipopolysaccharide (LPS)-stimulated macrophages, the most active plant was fractionated and evaluated using 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced mouse ear edema, measuring histopathological parameters and myeloperoxidase activity (MPO). Complementarily, the most active plant was further studied regarding its effects on the production of prostaglandin (PG) E~2~, cytokines and chemokines by LPS-stimulated macrophages. Additionally, the free radical scavenging potential was evaluated using NO, ABTS and DPPH scavenging assays.Table 1List of selected medicinal plant species employed in Colombian Caribbean Region to treat inflammatory related diseases including their ethno-pharmacological characteristics.Scientific nameLocal nameethnopharmacological usePart usedMode of preparation/administration routeReference*Calotropis procera* (Aiton) Dryand.\
(Apocynaceae)Algodón de sedaHeadache\
RheumatismRoots\
LeavesExudate/Oral\
Cataplasm/Topic[@b0155]\
[@b0150]*Ceratopteris pteridoides* (Hook.) Hieron.\
(Pteridaceae)Cola de caballoRespiratory Conditions\
Diuretic and CholelithiasicLeavesInfusion/Oral[@b0015]\
[@b0025]*Cordia alba (Jacq.) Roem, & Schult.*\
(Boraginaceae)Sauce sabaneroBronchitisBark, BudsOil Decoction, Infusion/Oral[@b0295]*Croton malambo* H.Karst.\
(Euphorbiaceae)CrotonRheumatism\
Pain\
InflammationBarkInfusion/Oral[@b0235]\
[@b0260]*Cryptostegia grandiflora* Roxb. ex R.Br.\
(Apocynaceae)Flor de muertoInflammation\
InfectionLeavesFresh plant in maceration/Cataplasm[@b0055]\
[@b0225]*Dracontium dubium* Kunth\
(Araceae)ChupaderaSnakebite\
InflammationRootPoultice/Topic[@b0165]*Maclura tinctoria* (L.) D. Don. ex Steud.\
(Moraceae)PalomoraInflammation\
Toothache\
RheumatismBarkLatex Drops/Topic\
Decoction, /Oral[@b0025]*Merremia umbellata* (L.) Hallier f.\
(Convolvulaceae)Juan de DiosInflammation and Infections\
Antiulcer\
RheumatismLeaves\
Whole PlantDecoction/Oral[@b0050]\
[@b0225]*Physalis angulata* L.\
(Solanaceae)Topo toropoInflammation and Infections\
Abdominal Cramps\
Asthma, Dermatitis, RheumatismCalyces\
Aerial Parts\
Whole PlantPoultice/Topic\
Infusion/Oral\
Infusion/Oral[@b0225]\
[@b0245]*Tabebuia rosea* (Bertol.) Bertero ex A.DC.\
(Bignoniaceae)Palo de rosaInflammation\
FeverBark\
Stem, Bark\
Decoction/Oral[@b0115]

2. Materials and methods {#s0010}
========================

2.1. Chemicals {#s0015}
--------------

12-O-tetradecanoyl-phorbol-13-acetate (TPA), indomethacin, ethylenediaminetetraacetic acid (EDTA), O-dianisidine, dulbecco's modified eagle medium (DMEM), penicillin--streptomycin, trypan blue, lipopolysaccharide (LPS), N-(\[3-(aminomethyl)phenyl\]methyl) ethanimidamide dihydrochloride (1400W), sodium nitrite, N-(1,1-naphthyl) ethylenediamine dihydrochloride, sulfanilamide, hematoxylin-eosin, 2,2-diphenyl-1-picrylhydrazyl (DPPH), ascorbic acid, 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), potassium persulfate (K~2~S~2~O~8~) were purchased from Sigma--Aldrich (St. Louis, MO, USA). Dichloromethane, dimethylsulfoxide, ethanol, and petroleum ether were obtained from Merck (Kenilworth, NJ, USA) or Carlo Erba (Val-de-Reuil, France). Hexadecyltrimethylammonium (HTAB), hydrogen peroxide (H2O2), bromide of 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) from Calbiochem® (San Diego, CA, USA). Fetal bovine serum (FBS) was obtained from GIBCO (Gaithersburg, MD, USA). All other chemicals and reagents used were of analytical grade.

2.2. Plant material and preparation of the extracts {#s0020}
---------------------------------------------------

The plant material was collected in the Caribbean coast of Colombia and plants were identified by a botanist at the Herbarium of the University of Antioquia (HUA, Medellin, Antioquia, Colombia) and the Botanical Garden Guillermo Piñeres (JBC, Túrbaco, Bolivar, Colombia) where voucher specimens were deposited ([Table 2](#t0010){ref-type="table"}).Table 2Plant information: list of evaluated plants, collection sites, vouchers, organs used, extraction solvent and yields.Scientific nameCollection siteVoucher numberUsed partExtract yields (%)*Calotropis procera*Galerazamba, Bolívar (10°47′52″N 75°15′41″W)HUA175327Leaves9,73*Ceratopteris pteridoides*San Bernardo del Viento, Cordoba (9°21′18″N 75°57′16″W)HUA166134Whole Plant6,79*Cordia alba*Pueblo Nuevo, Bolívar (10°44′26″N 75°15′43″W)HUA175329Flowers11,59*Croton malambo*Galerazamba, Bolívar (10°47′22″N 75°15′36″W)JBC 12,008Bark8,82*Cryptostegia grandiflora*Pueblo Nuevo, Bolívar (10°44′33″N 75°15′28″W)HUA175331Leaves6,92*Dracontium dubium*La Unión, Sucre (8°51′37″N 75°16′48″W)HUA 189,121RootN.D.*Maclura tinctoria*Pueblo Nuevo, Bolívar (10°44′42″N 75°15′48″W)JBC 12,013Bark5,33*Merremia umbellata*Pueblo Nuevo, Bolívar (10°44′22″N 75°15′35″W)HUA175331Leaves14,44*Physalis angulata*Pueblo Nuevo, Bolívar (10°44′N 75°15′W)HUA175328Calyces16,05*Tabebuia rosea*Túrbaco, Bolívar (10°19′55″N 75°24′51″W)HUA196871Bark9,20[^2]

Except for *Dracontium dubium*, all plant material were dried at room temperature, powdered and extracted by maceration with ethanol at room temperature until exhaustion. The crude ethanolic extract was filtered and the solvent evaporated under reduced pressure at 40 ± 5 °C using a rotary evaporator (Heidolph VV 2000, Heidolph, Kelheim, Germany). Tubers of *D. dubium* were washed, peeled and crushed in a minimum amount of water, then lyophilized (FreeZone® Dry 2.5, Labconco, Kansas, MO, USA). The powder obtained was finally extracted by maceration as described before.

*Physalis angulata* extract was fractionated through liquid-liquid partition with petroleum ether, dichloromethane and methanol-water (9:1) to obtain a petroleum ether (EF), dichloromethane (DF) and methanol fraction (MF).

Test extracts/fractions were dissolved in dimethyl sulfoxide (DMSO) or ethanol to obtain a stock solution, and stored at -20 °C. The final percentage of vehicle was adjusted to 0.1% (v/v) in cell culture experiments.

2.3. Phytochemical screening, flavonoids and polyphenols quantification {#s0025}
-----------------------------------------------------------------------

The phytochemical screening for presence of terpenes, steroids, quinones, glycosides, alkaloids and tannins was performed as reported by [@b0135]. Polyphenols were quantified using the Folín-Ciocalteu method with some modifications ([@b0080]). Briefly, the sample was mixed with Folín-Ciocalteu reagent (0.1 M), and 10 min later a solution of sodium carbonate (7.5%) was added. After incubating the mixture for 2 h at room temperature (RT), the Optic Density at 760 nm (OD~760~) was determined using a microplate reader (Multiskan EX Thermo, Waltham, MA, USA). Results are expressed as mg of gallic acid equivalents (GAE) per gram of extract.

Flavonoids were determined by the aluminum trichloride method with some modifications ([@b0005]). Samples were mixed with sodium nitrite (1.5%) and stirred for 10 min at RT, aluminum trichloride (3%) was then added and the mixture was now stirred for 5 min, before finally adding sodium hydroxide (1N). After 10 min, the OD~450~ was measured. Results are expressed as mg of catechin equivalents (QE) per gram of extract.

2.4. In vitro anti-inflammatory activity {#s0030}
----------------------------------------

### 2.4.1. Cell culture {#s0035}

RAW 264.7 (TIB-71™), murine macrophages were obtained from American Type Culture Collection (Manassas, VA, USA). The cells were cultured in DMEM supplemented with 2 mM [l]{.smallcaps}-glutamine, 10% FBS and penicillin (10 UI/mL)/streptomycin (10 μg/mL) at 37 °C and maintained in a humidified atmosphere containing 5% CO~2~. For all experiments, the cells were grown to 80--90% confluence.

### 2.4.2. Cell viability {#s0040}

The reduction of MTT to formazan was used to assess the effects of test extracts/fractions on cell viability following the protocol described by [@b0185]. Cells (2 × 10^5^ cells/mL) were seeded in 96-well microplates and treated with vehicle (DMSO/ethanol) or extracts/fractions (100--6.25 µg/mL) for 30 min, then stimulated with LPS (10 µg/mL). After 24 h, cells were incubated with MTT solution (0.25 mg/mL), 4 h later the formazan was dissolved in DMSO and the OD~550~ was measured. Triton X-100 (2%) was used as positive control. Percentages of cell survival relative to control group were calculated, as well as the lethal concentration 50% (LC~50~).

### 2.4.3. Pro-inflammatory mediators assessment {#s0045}

Cells (2 × 10^5^ cells/mL) were seeded in 24-well microplates and treated with vehicle, test extracts/fractions (100--6.25 µg/mL), 1400 W (2.50 µg/mL), dexamethasone (7.85 µg/mL), or rofecoxib (6.29 µg/mL) for 30 min, then stimulated with LPS (10 µg/mL). After 24 h, culture supernatants were collected and kept at -20 °C until further analysis.

NO release was determined using the Griess reaction ([@b0120]). Equal volumes of supernatants and Griess reagent (1:1 mixture of 0.1% N-(1-naphthyl) ethylenediamine dihydrochloride and 1% sulfanilamide in 5% H~3~PO~4~) were mixed and incubated at RT for 5 min. The OD~550~ was measured and compared with a sodium nitrite standard curve (1--200 µM). Percentage of inhibition was calculated using control cells and the IC~50~ was determined. To corroborate that NO depletion was caused by biological inhibition, instead of a scavenging effect of the extracts, the scavenging activity was measured using the method by [@b0090].

Production of PGE~2~, IL-1β, IL-6, TNF-α and CCL2 was measured using ELISA following the instructions of the manufacturer (eBiosciences, San Diego, CA, USA).

2.5. *In vivo* anti-edema activity {#s0050}
----------------------------------

### 2.5.1. Experimental animals {#s0055}

Female ICR mice (20--25 g) provided by the Instituto Nacional de Salud (Bogotá, Colombia) were allowed to acclimatize for at least two weeks before use and fed standard rodent food and water *ad libitum*. They were housed in filtered-capped polycarbonate cages and kept in a controlled environment (22 ± 3 °C and relative humidity: 65 to 75%), under a 12 h light/darkness cycle. All experiments were designed and conducted in accordance with the European Union regulations (CEC council 86/809) and approved by the Ethics Committee of the University of Cartagena (Minutes No. 32 August 4, 2011).

### 2.5.2. TPA-induced acute ear edema {#s0060}

The edema was induced by topical application of TPA (2.5 μg/ear) in acetone, according to the method described by [@b0070]. Groups (*n* = 6) were treated on the inner and outer surfaces of the right ear with the acetone dissolved treatment (1 or 05 mg in 20 μL of vehicle) or indomethacin (0.5 mg in 20 μL of vehicle), as reference drug. Immediately after, TPA was applied on both faces of the right ear. The left ear received only acetone, as a control. After 4 h, the animals were sacrificed, and a disk (6 mm diameter) removed from both ears (treated and untreated) was individually weighed on an analytical scale (Ohaus Pioneer^TM^, Parsippany, NJ, USA). Edema was indicated by the weight increase of the right ear disk over the left, and the anti-edema activity was expressed as inhibition percentage of edema.

### 2.5.3. Histopathology {#s0065}

Tissue samples were preserved in buffered formalin, embedded in paraffin, 5 μm sections were cut and stained with hematoxylin and eosin (H&E). The presence of edema, epidermal hyperplasia/hypertrophy, infiltration of mononuclear and polymorphonuclear cells, connective tissue disruption and dermal fibrosis was assessed by a blind pathologist using light microscopy (Axio Lab A1, Zeiss, Oberkochen, Germany). Parameters were scored from 0 to 3 (0, none; 1, mild; 2, moderate; 3, severe).

### 2.5.4. Myeloperoxidase (MPO) assay {#s0070}

MPO activity was measured according to the method described by [@b0035]. Ear tissue was weighed and homogenized in phosphate-buffered saline (PBS), pH 7.4. The homogenate was centrifuged at 2576*g* for 30 min at 4 °C. The pellet was again homogenized PBS, pH 6.0, containing 0.5% hexadecyl-trimethylammonium bromide (HTAB). This suspension was subjected to cycles of freezing/thawing and brief periods of sonication (15 s) and centrifuged at 2576*g* for 10 min at 4 °C. Supernatants were mixed with *O*-dianisidine dihydrochloride (0.067%) and hydrogen peroxide (0.003%), and incubated for 5 min before measuring the OD~450~. Enzyme activity was expressed as enzyme activity units, where 1 activity unit is defined as the amount of enzyme capable of metabolizing 1 µmol of hydrogen peroxide in 1 min at 25 °C.

2.6. Radical scavenging activity {#s0075}
--------------------------------

The ABTS-scavenging effect was determined using the method described by [@b0210], with modifications. ABTS (3.5 mM; in ethanol) and K~2~S~2~O~8~ (1.25 mM) were mixed with ascorbic acid (positive control) or test extracts/fractions and incubated at RT for 5 min. The scavenging of the ABTS radical was determined by measuring the OD~405~. The DPPH-scavenging effect was determined using the method described by [@b0040], with some modifications. In brief, DPPH (100 µg/mL), was mixed with ascorbic acid or test extracts/fractions, and then incubated at RT for 30 min. The scavenging of the DPPH radical was determined by measuring the OD~550.~ Vehicles were used as negative controls.

2.7. Statistical analysis {#s0080}
-------------------------

Results are expressed as the mean ± standard error of the mean (S.E.M) of at least two independent experiments. IC~50~ and LC~50~ were calculated employing non-linear regression and expressed as mean and its 95% confidence interval. Data were analyzed using one-way analysis of variance (ANOVA), followed by Dunnett's and Tukey's post hoc tests. Values of *P* \< 0.05 were considered significant.

3. Results and discussion {#s0085}
=========================

Ethnopharmacological studies allow not only to document traditional knowledge of plants, but to engage policy-makers in designing appropriate strategies for the conservation of biodiversity and cultural knowledge related to medicinal plants. We contribute to this endeavor through our bioprospecting program, focused on isolation of bioactive compounds or therapeutically useful extracts/fractions from plants of the Colombian Caribbean region. In the first part of our work the anti-inflammatory potential of 10 plants traditionally used to alleviate inflammation ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}) were evaluated based on their capacity to inhibit NO production by LPS-stimulated RAW 264.7 macrophages. In the second part, we focused on the fractionation and evaluation of the most active extract, as well as some insights into the mechanism of action.

3.1. Effect of the plant extracts on the NO production by LPS-stimulated RAW 264.7 macrophages {#s0090}
----------------------------------------------------------------------------------------------

Stimulation of RAW 264.7 macrophages with LPS (10 μg/mL) elicited a significant accumulation of nitrite in the medium (41.36 ± 0.63 μM). As can be seen in [Table 3](#t0015){ref-type="table"}, NO production was reduced by test extracts at different degrees. We employed the NO inhibition rates (IR) to classify plants among four categories: inactive (−), when the IR was below 20%; weakly active (+), when between 20 and 40%; moderately active (++), with IRs between 40 and 60%; and highly active (+++) when the IR was higher than 60%. Extracts were evaluated at non-toxic concentrations (cell viability above 85%) as determined by the MTT assay ([Table 3](#t0015){ref-type="table"}), and did not show any significant NO-scavenging effect (data not shown). Therefore, the NO inhibition presented by the extracts is due to an effect on the cellular processes and not an *in vitro* scavenging effect or cytotoxicity.Table 3Evaluation of the cell viability and NO inhibition potential of extracts obtained from Colombian Caribbean Coast plants on LPS-stimulated RAW 264.7 macrophages.PlantConcentration (µg/mL)% Cell viability% Nitrite inhibitionRank1*Calotropis procera*100100 ± 6.70^\*\*^45.11 ± 4.50++2*Ceratopteris pteridoides*10099.10 ± 1.23^\*\*\*^33.48 ± 2.29+3*Cordia alba*100100 ± 8.91^\*\*\*^33.15 ± 2.69+4*Croton malambo*5086.56 ± 1.66^\*\*\*^97.05 ± 2.15+++5*Cryptostegia grandiflora*10098.48 ± 0.63^\*\*\*^70.47 ± 0.81+++6*Dracontium dubium*10096.45 ± 0.65^\*\*\*^7.23 ± 1.52--7*Maclura tinctoria*100102.11 ± 1.61^\*\*\*^41.07 ± 2.12++8*Merremia umbellata*100100 ± 0.81^\*\*\*^56.06 ± 1.74++9*Physalis angulata*2593.84 ± 1.41^\*\*\*^91.94 ± 1.97+++10*Tabebuia rosea*10096.65 ± 0.60^\*\*\*^9.23 ± 1.89--111400W2.50100 ± 1.59^\*\*\*^83.88 ± 1.07+++[^3]

At the evaluated concentrations, *D. dubium* and *T. rosea* showed the lowest activity with IRs below 10%. Although previous studies demonstrated the anti-inflammatory activity of *T. rosea* ([@b0095]) and the anti-edema properties of *Dracontium* species ([@b0110]), our results are in agreement with several studies that demonstrated that NO production is not inhibited by extracts from plants belonging to the *Tabebuia* genus at concentrations below 200 µg/mL ([@b0045]). This suggests that the inhibition of NO production might not be a decisive target involved in the effect of these plants. On the other hand, the plants classified as weakly active, *C. pteridoides* and *C. alba*; have no reports of anti-inflammatory activity. However, there are reports of compounds isolated from other plants of the *Cordia* genus with this biological activity ([@b0010], [@b0105]). In this sense, their potential as treatment for inflammation could not be denied, as we employed a stringent top test concentration (100 µg/mL) and focused only on NO production.

To our knowledge, the anti-inflammatory effect of *M. tinctoria* (moderately active) has not been previously reported, positioning our study as the first precedent of the potential of this plant to treat inflammation. On the other hand, the results for *M. umbellata*, also classified as moderately active, are consistent with our previous report that determined its effectiveness reducing the edema and MPO activity in the TPA-induced mouse ear edema model; and supporting the traditional use given to this species ([@b0050]). Likewise, *C. procera* leaves have also been reported to reduce edema and itching on different *in vivo* models ([@b0230]), our results corroborate these findings and place the inhibition of the NO production as a possible target, partially responsible for *M. umbellata* and *C. procera* leaves anti-inflammatory activity.

The extracts of *C. grandiflora*, *C malambo* and *P. angulata* were catalogued as highly active. *C. grandiflora* extract inhibited NO production by 70%, in accordance with our previous findings that proved its capacity to reduce edema, MPO activity and leukocyte infiltration ([@b0055]). Due to the cytotoxic effect of the *C. malambo* and *P. angulata* extracts, they were evaluated at the lower concentrations. Despite this, both extracts were highly active, with IRs above 90%, making them the most promising extracts in the group. The efficacy of NO inhibition was estimated with the Selectivity Index (SI), defined as LC~50~/IC~50~, and used as criteria to choose the best fractionation candidate. As seen in [Table 4](#t0020){ref-type="table"}, *C. malambo* and *P. angulata* had the lowest IC~50~ values. Nevertheless, the SI for *P. angulata* (32.15) doubled the SI for *C. malambo* (16.05), suggesting the potential of *P. angulata* as a safer anti-inflammatory agent and a better candidate for fractionation.Table 4Assessment of the LC~50~, IC~50~ (NO), and SI of the extracts with the highest NO inhibition potential among the tested plants group.PlantLC~50~ ± confidence intervals (µg/mL)IC~50~ ± confidence intervals (µg/mL)SI1*Croton malambo*113.907 (97.537--131.361)7.097 (6.229--8.199)16.052*Cryptostegia grandiflora*\>10043.442 (41.748--45.136)\>2.304*Physalis angulata*130.628 (114.505--144.937)4.063 (3.541--4.665)32.15[^4]

The anti-inflammatory activity of *P. angulata* has been widely studied, proving its capacity to reduce inflammation and modulate NO production by extracts from roots ([@b0020]) and aerial parts ([@b0065], [@b0275]) as well as by different isolated compounds ([@b0200], [@b0250], [@b0270]). However, our results constitute the first report of anti-inflammatory potential of its calyces. The distinctive calyx of the *Physalis* genus is an important structure formed by sepals as a source of carbohydrates for development and protection of the fruit against environmental threats ([@b0205]). Hence, it represents a rich source of novel bioactive metabolites with a vast pharmacological potential, this is supported by other recent reports ([@b0090], [@b0285]).

3.2. Assessment of the anti-inflammatory effect of the primary fractions obtained from *P. angulata* calyces {#s0095}
------------------------------------------------------------------------------------------------------------

The total ethanolic extract of the calyces of *P. angulata* was fractionated through liquid-liquid partition, obtaining three primary fractions, a petroleum ether (EF), dichloromethane (DF) and methanol fraction (MF). These fractions were evaluated for its potential to inhibit NO production on RAW 264.7 macrophages.

EF and MF were evaluated both at 75 µg/mL whereas DF was evaluated at 25 µg/mL, in accordance with the MTT cell viability test (data not shown). Despite the difference in concentration, DF had a significantly higher NO IR (97%), compared to EF and MF, with IR below 50% ([Table 5](#t0025){ref-type="table"}), indicating that the bioactive metabolites were concentrated in the medium polarity fraction. Moreover, DF displayed a significant concentration-dependent inhibition with IC~50~ of 2.48 (2.23--2.77) µg/mL, showing a comparable activity than the iNOS selective inhibitor 1400 W (IC~50~ of 3.72 (2.98--4.57) µg/mL). Moreover, none of the fractions displayed NO scavenging effects (data not shown).Table 5Evaluation of the NO inhibition potential of fractions obtained from *Physalis angulata* calyces on LPS-stimulated RAW 264.7.*P. angulata* fractionsConcentration (µg/mL)% Nitrite inhibitionRank1Ether (EF)7542.897 ± 1.791++2Dichloromethane (DF)2597.079 ± 0.494+++3Methanol (MF)7549.232 ± 1.138+[^5]

The extract and fractions were also evaluated on the TPA-induced ear edema model. TPA is an irritating agent that activates protein kinase C (PKC), increasing the levels of pro-inflammatory mediators such as PGE~2~, TNF-α, IL-1β, and IL-6; which are accompanied by edema, epidermal hyperplasia and immune cell infiltration ([@b0100], [@b0190]). TPA application increased the ear thickness after 4 h ([Fig. 1](#f0005){ref-type="fig"}A), ear edema was significantly ameliorated by treatment with extract and fractions from *P. angulata* calyces. DF showed a dose-dependent reduction of the edema, with the dose of 1 mg/ear inhibiting up to 60% (*P* \< 0.001), an effect comparable to the produced by indomethacin (0.5 mg/ear). None of the tested extract/fractions produced evident local or systemic adverse effects, suggesting that their topical administration is well tolerated.Fig. 1*In vivo* evaluation of the anti-inflammatory effect of the extract and fractions obtained from the calyces of *P. angulata* in the TPA-induced mice ear edema. **TE(1):** Total extract (1 mg/ear), **EF(1):** Ether fraction (1 mg/ear), **MF(1):** Methanol fraction (1 mg/ear), **DF(1):** Dichloromethane fraction (1 mg/ear), **DF(0,5):** Dichloromethane fraction (0,5 mg/ear), **Indo:** Indomethacin. **(A):** Ear weight difference (mg) and inflammation inhibition percentage, circular 6 mm diameter sections of both treated and non-treated ear were weighted. **(B):** Enzymatic activity measured in ear tissue homogenized expressed as MPO units/mg tissue. Each value represents mean ± S.E.M. (*n* = 6) from at least two independent experiments. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 compared with TPA group (One way ANOVA). &&&*P* \< 0,001 compared with Control group (One way ANOVA).

The neutrophil accumulation is a characteristic feature of TPA-induced edema ([@b0240]) and is measured indirectly by the increase of MPO activity (*P* \< 0.001). As seen in [Fig. 1](#f0005){ref-type="fig"}B, treatment with extract and fractions from *P. angulata* significantly decreased the MPO activity relative to the TPA group (*P* \< 0.001). The highest activity was exerted by both MF and DF, which inhibited the enzymatic activity by over 71% at 1 mg/ear (*P* \< 0.001). Additionally, DF also showed MPO inhibition at 0.5 mg/ear (39% inhibition *P* \< 0.001) indicating a dose-dependent effect.

The anti-edema effect of the test extract and fractions was confirmed by histological examination of the ear tissue ([Fig. 2](#f0010){ref-type="fig"}). The edema on the TPA group (score: 16), was accompanied by increased ear thickness, disruption of tissue structure, immune cell infiltration, hyperplasia and hypertrophy of dermis, and epidermis ([Fig. 2](#f0010){ref-type="fig"}B). Administration of extract and fractions reduced the tissue damage induced by TPA ([Fig. 2](#f0010){ref-type="fig"}D--H), DF showed the highest anti-edema activity, restoring tissue architecture and diminishing the edema, cell infiltration which is reflected in the reduced lower histological score (Score: 4) ([Fig. 2](#f0010){ref-type="fig"}G and H) similar to the effect produced by indomethacin with a histological score of 2 ([Fig. 2](#f0010){ref-type="fig"}C).Fig. 2Histology samples from the TPA-induced ear edema test, ear tissue was dehydrated, embedded in paraffin and stained with Hematoxylin-Eosin. All pictures were taken in an Axio Lab A1 microscope (Zeiss, Oberkochen, Germany) and correspond to the 10X zoom. **(A)** Control group, **(B)** TPA group, **(C)** Indomethacin (0,5 mg/ear), **(D)** TE (1 mg/ear), **(E)** EF (1 mg/ear), **(F)** MF (1 mg/ear), **(G)** DF (1 mg/ear) and **(H)** DF (0,5 mg/ear).

Taken together, observations at macroscopic and histopathological level reveal that DF has the highest anti-inflammatory potential and represents a prominent source of bioactive metabolites. These *in vivo* results support the use of the NO determination by the Griess assay as a suitable method for a bio-guided fractionation of potentially anti-inflammatory plant extracts, in accordance with [@b0085].

3.3. Effect of DF on the production of pro-inflammatory mediators by LPS-stimulated RAW 264.7 macrophages {#s0100}
---------------------------------------------------------------------------------------------------------

Macrophages are critical effectors and regulators of inflammation and the immune response. When stimulated with LPS, macrophages undergo classical M1 activation through activation of Toll-like receptor 4 (TLR4) ([@b0145]). TLR4 modulation by LPS promotes activation effector functions, NO production and reactive oxygen intermediates (ROI), PGE~2~, cytokines (IFN-β, IL-1β, IL-6, IL-12, and TNF-α) and chemokines like the monocyte chemotactic protein-1 (MCP-1, CCL2), as well as other important mediators of the inflammatory response ([@b0030]). M1 macrophages and high NO levels positively correlate with many inflammatory diseases ([@b0125]). CCL2 provokes mast cell, eosinophil, and macrophage recruitment and activation in rat skin ([@b0265]) and has a critical role in the onset of inflammation and fibrosis ([@b0300]).

Considering the results showed by DF *in vivo*, we evaluated its effect on pro-inflammatory mediators using LPS-stimulated RAW 264.7 macrophages. As shown in [Fig. 3](#f0015){ref-type="fig"}A--F, high concentration of NO, PGE~2~, IL-1β, IL-6, TNF-α, and CCL2 was observed after LPS stimulation, with at least a 4-fold increase (*P* \< 0.001). In the absence of LPS, incubation with DF did not modify the release of pro-inflammatory mediators (data not shown). DF significantly inhibited the LPS-induced release of all the evaluated pro-inflammatory mediators in a concentration-dependent manner ([Fig. 3](#f0015){ref-type="fig"}A--F), with IC~50~ values below 20 µg/mL, suggesting a potential immunomodulatory effect.Fig. 3Effect of the dichloromethane fraction (DF) on the production of pro-inflammatory mediators by LPS-stimulated RAW 264.7 macrophages. **(A):** NO•, **(B):** PGE2, **(C):** IL-1 β, **(D):** IL-6, **(E):** TNF-α, **(F):** MCP-1. Cells were incubated for 24 hours after stimulation and treatment with DF. Then supernatants were collected and mediators were measured through ELISA kits, except the NO• which was measured with the Griess reaction, as described in Methods. Each value represents mean ± SEM (*n* = 6). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 compared with LPS group (One way ANOVA).

Collectively, we have demonstrated that calyces of *P. angulata* promote an anti-inflammatory state of macrophages, decreasing the release of pro-inflammatory mediators. Such effects are, consistent with previous *in vitro* and *in vivo* reports of extracts and compounds obtained from other parts of the *P. angulata* plant, which inhibited NO, PGE~2~, IL-6, IL-1β, IL-12, and TNF-α production ([@b0020], [@b0270]); or increased IL-4 and IL-10 levels ([@b0275], [@b0310]), distinctive cytokines of M2 macrophages. We hypothesized that the effects of DF could be related with the blockage of the TLR4 signaling pathway or a profile transition from M1 to M2 macrophages ([@b0175]), whichever the case might be, further research is needed to determine the actual mechanisms.

Compounds isolated from the calyces of species of *Physalis* genus as physalins (*Physalis alkekengi* L.), withanolides (*Physalis pruinosa* L.) and sucrose esters (*Physalis peruviana* L.), have also show anti-inflammatory potential by the modulation of stimulated macrophages and expression of NO, PGE~2~, IL-6, CCL2 or TNF-α, through the inhibition of NF-κB activation ([@b0090], [@b0140], [@b0285]). Although, we did not study in detail the chemical composition of DF, the phytochemical screening of the fraction showed presence of glycosides, steroids and terpenes ([Table 6](#t0030){ref-type="table"}) and colorimetric quantification revealed a low quantity of polyphenols (8.78 ± 0.165 mg Gallic acid/g extract) whereas flavonoids were not detectable. Due to the low concentration of these pharmacologically important secondary metabolites, we think that the biological effects of the fraction may be more influenced by glycosides as they appear to be the most abundant.Table 6Phytochemical characterization of the dichloromethane fraction obtained from the total ethanolic extract of the calyces of *Physalis angulata*.Metabolite*P. angulata* DFFlavonoids−Terpenes and/or steroids++Quinones−Glycosides+++Steroidal core++Alkaloids−Tannins−[^6]

As reactive oxygen species are commonly known as triggers of inflammatory processes and its production is considered a potential target of anti-inflammatory drugs ([@b0075]), we evaluated the potential scavenging effect of *P. angulata* calyces, using DPPH and ABTS assays. The results showed that the total extract and fractions have no radical scavenging effect (100 µg/mL), suggesting that the effects observed, are not related to antioxidant activity (data not shown).

4. Conclusions {#s0105}
==============

In short, our results confirm and support the ethnopharmacological employment of the selected plants in the Colombian folk medicine, constituting the first scientific report of anti-inflammatory potential for *Ceratopteris pteridoides, Cordia alba,* and *Maclura tinctoria*. The extract obtained from calyces of *Physalis angulata* had the highest anti-inflammatory potential according to the *in vitro* results, and the dichloromethane fraction inhibited the production of inflammatory mediators (NO, PGE~2~, IL-6, IL-1β, TNF-α, and CCL2) by LPS-induced macrophages, as well as reducing the edema, cell infiltration and MPO activity in a TPA-induced mice ear edema assay. To our knowledge, this is the first scientific report of the anti-inflammatory potential of the calyces of *P. angulata*, placing them as promising source of bioactive metabolites. Nevertheless, a bio-guided isolation of bioactive compounds is still necessary.
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[^1]: These authors contributed equally to this work.

[^2]: All extracts were obtained by maceration with ethanol 96% and concentrated in a rotaryevaporator. The yields were calculated as: \[Dry Concentrated Extract (g)/Dry Material (g)\] × 100. N.D.: Not determined.

[^3]: The cell viability was measured using the MTT assay and the NO^•^ inhibition was assessed with the Griess assay as described in Methods. Extracts were classified by their activity as highly active (IR ≥ 60%, +++), moderately active (60%\>IR ≥ 40%, ++), weakly active (40%\>IR ≥ 20%, +), and inactive (IR ≤ 20%, −). 1400 W: N-(3-(aminomethyl) benzyl)acetamidine. Each value represents mean ± SEM (n = 8) from at least two independent experiments.\*P \< 0.05, ^\*\*^P \< 0.01, ^\*\*\*^P \< 0.001 compared with control group (One way ANOVA).

[^4]: The cell viability was measured using the MTT assay and the NO inhibition was assessed with the Griess assay as described in Methods. IC~50~ and LC~50~ were calculated with non-linear regression and expressed as mean and its 95% confidence interval (*n* = 8) from at least two independent experiments.

[^5]: The cell viability was measured using the MTT assay and the NO inhibition was assessed with the Griess assay. Fractions were classified by their activity as highly active (IR ≥ 60%, +++), moderately active (60%\>IR ≥ 40%, ++), weakly active (40%\>IR ≥ 20%, +), and inactive (IR ≤ 20%, −). Each value represents mean ± SEM (*n* = 8) from at least two independent experiments. \**P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.001 compared with control group (One way ANOVA)

[^6]: (−) Not detected, (+) Weak presence, (++) Moderate presence and (+++) Strong presence.
